drugset / Trial / NCT00318812
Heme Iron Polypeptide for Iron Deficiency Anemia in Chronic Renal Failure
RandomizedParallel-groupSingle-blindTreatment
Summary
The purpose of this study is to determine if oral Heme Iron Polypeptide is as effective as intravenous (IV) iron sucrose in the treatment of iron-deficiency anemia for patients with chronic kidney disease.
Timeline
- Start
- 2007-05
- Primary completion
- 2011-12
- Completion
- 2011-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Heme Iron Polypeptide | Unknown | 11 mg | Oral |
| Comparator | Iron sucrose | Unknown | 200 mg | Intravenous |